Rapid in Vitro Assessment of Clostridioides difficile Inhibition by Probiotics Using Dielectrophoresis to Quantify Cell Structure Alterations
- 8 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (5), 1000-1007
- https://doi.org/10.1021/acsinfecdis.9b00415
Abstract
Clostridioides difficile (C. difficile) infection (CDI) is the primary cause of nosocomial antibiotic-associated diarrhea, with high recurrence rates following initial antibiotic treatment regimens. Restoration of the host gut microbiome through probiotic therapy is under investigation to reduce recurrence. Current in vitro methods to assess C. difficile deactivation by probiotic microorganisms are based on C. difficile growth inhibition, but the cumbersome and time-consuming nature of the assay limits the number of assessed permutations. Phenotypic alterations to the C. difficile cellular structure upon interaction with probiotics can potentially enable rapid assessment of the inhibition without the need for extended culture. Because supernatants from cultures of commensal microbiota reflect the complex metabolite milieu that deactivates C. difficile, we explore coculture of C. difficile with an optimal dose of supernatants from probiotic culture to speed growth inhibition assays and enable correlation with alterations to its prolate ellipsoidal structure. Based on sensitivity of electrical polarizability to C. difficile cell shape and subcellular structure, we show that the inhibitory effect of Lactobacillus spp. supernatants on C. difficile can be determined based on the positive dielectrophoresis level within just 1 h of culture using a highly toxigenic strain and a clinical isolate, whereas optical and growth inhibition measurements require far greater culture time. We envision application of this in vitro coculture model, in conjunction with dielectrophoresis, to rapidly screen for potential probiotic combinations for the treatment of recurrent CDI.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1R21AI130902-01)
- Air Force Office of Scientific Research (FA2386-18-1-4100)
- University of Virginia
This publication has 36 references indexed in Scilit:
- Clostridium difficile, Aging, and the Gut: Can Microbiome Rejuvenation Keep Us Young and Healthy?The Journal of Infectious Diseases, 2018
- Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysisInternational Journal of General Medicine, 2016
- The Microbiota and Microbiome in Aging: Potential Implications in Health and Age‐Related DiseasesJournal of the American Geriatrics Society, 2015
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015
- Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibioticAnnals of the New York Academy of Sciences, 2013
- Treatment of refractory and recurrent Clostridium difficile infectionNature Reviews Gastroenterology & Hepatology, 2011
- Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and CentenariansPLOS ONE, 2010
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomesJournal of Infection, 2009
- Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human IntestineCell, 2006